RUDN: RUDN chemists have shown how a new antitumor drug interacts with blood proteins
RUDN chemists investigated in detail the molecular mechanism of interaction of the newly created antitumor drug with blood proteins. The results will not only allow us to judge the effectiveness of the drug, but also are of interest from!-->…